Allergan inc (AGN)
CashFlow / Quarterly
Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Cash flows from operating activities:
Net earnings

539,100

313,400

418,400

257,900

312,300

300,800

361,200

14,400

325,200

250,600

296,400

230,300

279,700

251,000

248,600

158,800

263,100

-668,700

241,500

169,000

222,800

179,200

176,800

45,000

Non-cash items included in net earnings:
Depreciation and amortization

63,100

64,000

60,400

60,600

59,500

60,700

61,300

73,100

65,200

64,500

64,200

62,700

64,000

63,500

62,500

63,400

63,200

61,300

66,300

66,300

65,800

64,100

63,200

69,000

Amortization of original issue discount and debt issuance costs

700

700

700

700

700

700

700

500

500

400

500

500

500

400

1,300

7,500

7,400

7,100

7,000

6,900

6,800

6,700

6,700

7,300

Amortization of net realized gain on interest rate swaps

-3,800

-3,800

-3,700

-3,700

-3,600

-3,600

-3,600

-3,600

-3,500

-3,500

-400

-300

-300

-300

-400

-300

-300

-300

-400

-300

-300

-300

-400

-300

Deferred income tax benefit

-66,400

-17,300

0

3,900

-58,100

-32,800

-12,600

-88,700

-47,700

-28,300

-9,700

-2,600

-18,100

-6,600

-17,600

-26,600

-98,500

-144,700

6,200

-12,100

-56,600

-12,400

-3,500

-40,300

Acquired in-process research and development technology

-

-

-

10,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal and impairment of assets

-21,100

-8,000

-500

-200

-1,900

-2,700

-700

-500

-700

-5,000

100

-100

-2,100

0

600

1,500

-30,000

11,400

300

400

-7,200

6,300

200

-3,100

Loss on extinguishment of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-10,600

10,600

0

-5,300

Unrealized (gain) loss on derivative instruments

18,200

34,100

-10,900

-4,200

6,100

-7,600

10,600

1,300

-100

-7,100

4,400

-12,500

-900

16,800

2,100

-6,900

-14,600

15,200

-8,900

700

-30,800

31,700

-11,700

-2,800

Expense of share-based compensation plans

52,600

41,000

31,400

34,700

29,800

27,800

27,800

29,000

29,400

26,900

26,800

26,000

22,000

22,400

21,100

20,800

20,500

18,100

17,100

18,200

18,600

16,900

18,200

98,200

Loss on sale of discontinued operations

0

0

0

0

-3,300

-58,700

0

-346,200

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets and related costs

-

-

-

-

-

-

-

-

-

-

-

-

0

4,300

0

16,100

-

-

-

-

-

-

-

-

(Income) expense from changes in fair value of contingent consideration

400

-18,900

3,700

-300

65,900

1,500

-2,500

5,800

-10,400

2,400

12,800

600

9,600

0

2,300

0

-

-

-

-

-

-

-

-

Restructuring charges

38,100

185,500

-1,500

24,300

600

600

0

4,300

1,000

3,800

900

0

0

-100

100

4,600

-500

100

100

600

3,600

4,200

1,000

42,100

Intangible asset impairment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Loss on investments

-3,100

0

0

0

0

0

0

-3,700

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Trade receivables

-28,500

-14,300

55,000

103,500

-33,800

-19,600

40,200

152,800

-116,800

-1,100

28,100

124,100

23,900

1,900

65,600

14,200

82,800

36,500

-59,500

11,600

31,700

-46,600

23,400

9,200

Inventories

18,900

14,100

-1,400

12,200

4,300

3,000

19,700

-100

-4,900

2,200

5,500

4,500

4,600

14,200

-1,500

6,700

4,700

-7,500

11,500

-3,100

-118,500

86,300

-31,700

-3,800

Other current assets

13,800

13,700

2,600

-6,800

24,000

5,500

-20,900

-7,800

-3,400

20,400

7,300

-8,300

6,700

13,900

7,800

4,700

-10,400

-11,500

37,500

-22,900

-29,600

46,500

-13,800

-8,000

Other non-current assets

16,200

-3,300

12,100

4,700

7,300

-400

5,300

3,300

2,400

-49,900

-2,500

5,900

0

6,900

1,100

5,400

29,100

-8,000

200

-2,700

40,500

-19,900

2,500

-2,800

Accounts payable

7,000

-21,100

-7,400

23,400

14,800

29,000

22,100

-28,500

19,100

9,600

-500

4,500

12,800

-3,100

-7,400

-21,600

32,000

-1,200

-56,300

34,100

-25,100

40,600

-2,100

9,100

Accrued expenses

12,900

67,400

82,400

-46,800

52,100

76,900

47,500

-66,300

-40,900

80,800

51,800

-18,600

17,200

19,100

56,500

-53,700

1,000

31,900

60,800

-59,300

40,000

31,600

26,800

-82,200

Income taxes

9,500

-19,100

-30,900

-83,500

44,500

34,500

22,500

-36,600

14,000

4,300

22,900

11,200

18,100

30,000

-51,800

-16,100

3,900

-22,200

22,500

-21,800

44,400

-12,200

9,200

-43,000

Other liabilities

43,300

1,700

-13,300

-6,200

-11,900

2,400

11,300

15,300

2,200

9,700

6,600

8,200

4,400

-6,200

4,500

10,900

2,000

13,100

-7,900

-12,300

11,700

29,000

5,700

-5,000

Net cash provided by operating activities

694,200

594,500

473,300

165,800

515,300

579,000

481,500

119,600

499,900

461,700

429,400

208,900

380,400

320,200

243,100

138,200

-357,000

309,600

338,000

173,300

321,800

342,300

332,700

116,500

Cash flows from investing activities:
Purchases of short-term investments

0

159,900

445,600

664,300

381,100

459,700

134,800

50,000

160,600

199,900

284,800

219,900

179,900

66,400

174,900

149,900

324,800

499,300

0

0

-

-

-

-

Purchases of equity investments

10,300

0

0

10,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisitions, net of cash acquired

0

67,500

0

0

0

0

20,700

871,400

346,100

0

0

3,100

2,500

91,900

7,000

0

0

6,100

0

63,700

-

-

-

-

Additions to property, plant and equipment

58,500

75,500

63,500

46,400

74,500

35,000

38,700

23,700

45,200

40,800

34,200

23,100

43,200

29,100

29,200

17,100

52,500

20,300

17,500

12,500

45,700

22,700

15,900

11,500

Additions to capitalized software

6,400

4,000

5,000

3,600

3,200

3,000

2,900

2,700

6,400

3,800

2,000

1,700

3,300

1,800

2,800

3,300

3,100

3,500

3,800

2,900

4,500

4,700

8,500

8,900

Additions to intangible assets

0

5,000

10,000

0

0

0

0

300

0

600

3,500

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities of short-term investments

219,600

410,900

719,800

465,600

302,700

119,900

0

260,600

179,900

224,900

329,800

50,000

66,400

299,800

124,800

649,300

75,000

0

0

0

-

-

-

-

Proceeds from sale of business

0

0

0

1,800

42,700

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contractual purchase price adjustment to prior acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,700

-

-

-

-

Proceeds from sale of property, plant and equipment

200

100

100

100

100

300

0

100

500

700

300

300

100

300

600

200

400

0

0

0

-

-

-

-

Net cash provided by (used in) investing activities

144,600

99,100

195,800

-256,800

-113,300

-377,500

-197,100

-687,400

-377,900

-19,500

5,600

-197,500

-161,900

111,100

-87,600

479,200

-327,400

-547,700

-21,300

-80,800

-53,200

-12,300

-12,800

-20,400

Cash flows from financing activities:
Repayments of convertible borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

98,300

Dividends to stockholders

14,900

14,900

14,900

14,900

14,800

14,900

14,800

14,900

15,000

15,000

15,200

15,200

15,300

15,200

15,300

15,300

15,200

15,100

15,200

15,100

15,100

15,200

15,100

15,200

Payments to acquire treasury stock

4,100

1,100

436,000

398,000

1,400

200

700

648,400

185,700

174,300

332,100

216,900

87,700

75,000

136,100

162,900

87,100

63,200

76,100

59,600

-

-

-

-

Payments of contingent consideration

0

0

2,600

7,600

50,100

0

1,000

10,100

0

0

0

5,100

0

0

100

2,900

0

0

0

0

-

-

-

-

Net borrowings (repayments) of notes payable

16,300

-5,100

-100

5,400

18,400

-14,400

-5,600

8,400

8,000

-1,600

-45,300

3,800

5,000

2,800

14,700

8,200

9,600

5,400

-4,900

-3,500

1,800

2,500

11,100

-3,300

Debt issuance costs

0

0

0

0

0

0

1,100

3,700

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of senior notes, net of discount

0

0

0

0

0

0

0

598,500

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Sale of stock to employees

132,700

52,500

118,200

217,600

19,200

19,500

28,400

112,200

92,500

26,800

40,000

87,100

58,300

27,500

97,800

80,400

143,400

33,800

20,800

36,000

30,900

22,200

5,400

5,000

Excess tax benefits from share-based compensation

53,400

16,200

38,900

59,000

4,100

1,800

1,000

30,800

21,200

3,500

6,100

14,900

16,900

3,100

13,100

4,600

22,400

3,700

1,000

0

4,400

2,900

-100

100

Net cash (used in) provided by financing activities

183,400

47,600

-296,500

-138,500

-42,600

-8,200

6,200

72,800

-79,000

-160,600

-346,500

-131,400

-22,800

-56,800

-834,800

-87,900

73,000

606,600

-74,400

-42,200

-16,900

-23,300

-29,600

-111,700

Effect of exchange rate changes on cash and equivalents

-21,600

-20,300

2,000

-1,300

400

9,000

-5,400

-8,000

3,800

4,700

-11,500

5,600

-1,600

-19,000

5,000

10,100

-700

15,200

-12,400

-7,700

-3,200

3,800

9,500

-6,500

Net increase in cash and equivalents

1,000,600

720,900

374,600

-230,800

359,800

202,300

285,200

-503,000

46,800

286,300

77,000

-114,400

194,100

355,500

-674,300

539,600

-612,100

383,700

229,900

42,600

248,500

310,500

299,800

-22,100

Supplemental disclosure of cash flow information
Cash paid for:
Interest, net of amount capitalized

23,800

17,700

24,400

17,500

28,300

18,800

24,300

11,900

24,300

8,500

18,500

12,900

17,800

12,400

22,400

11,900

22,700

1,100

23,000

1,200

22,200

600

23,200

7,700

Income taxes, net of refunds

66,800

129,700

161,800

129,500

164,500

99,200

114,300

77,300

145,700

95,000

99,300

67,000

91,700

69,800

144,600

93,200

141,700

107,200

57,300

104,600

96,600

67,700

69,000

99,300